Signature and Molecular Mechanism of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Adenocarcinoma

Table 1

Clinical phenotype of TCGA-LUAD.

Phenotype	Group	No. (%)
Age		136 (27.36%)
		351 (70.62%)
	Unknown	10 (2.02%)
Gender	Female	269 (54.12%)
	Male	228 (45.88%)
Stage	Stage I	267 (53.72%)
	Stage II	118 (23.74%)
	Stage III	80 (16.1%)
	Stage IV	25 (5.03%)
	Unknown	7 (1.41%)
EGFR mutation	Mut	79 (15.9%)
	Wd	190 (38.23%)
	Unknown	228 (45.87%)
EML4-ALK translocation	Yes	33 (6.64%)
	No	206 (41.45%)
	Unknown	258 (51.91%)